FDA Drafts Guidance To Spur Uptake In Continuous Manufacturing
Executive Summary
FDA is hoping that by laying out its expectations for continuous manufacturing, applicants will feel more comfortable about adopting such approaches instead of sticking with conventional batch methods.
You may also be interested in...
Generics Firms Deterred From Continuous Manufacturing
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
Continuous Manufacturing: Cost, Lack Of Know-How Have Deterred Generic Firms, Prof Says
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
US FDA Thinking Small To Solve Big Shortages
FDA is joining the government’s bioresponse and defense efforts to develop small, mobile, on-demand manufacturing systems as next-tech solutions to dwindling domestic supply sources for essential drugs.